Compare HCA Health Inc (HCA) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Lithium Americas Corp — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Lithium Americas Corp trades at $2.39 (market cap $876.06M). The key difference: HCA Health Inc is far larger — about 108.5× Lithium Americas Corp's market cap, and HCA Health Inc pays a 0.71% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Lithium Americas Corp for 27 Days on average.
| HCA | LAC | |
|---|---|---|
Market Cap | $95.08B | $876.06M |
Volume | 998,787 | 9,397,178 |
Sector | Health | Basic Materials |
52-Week High | $545.13 | $10.05 |
52-Week Low | $361.32 | $2.36 |
Typical Hold Time | 76 Days | 27 Days |
Enterprise Value | $145.62B | $1.21B |
Dividend Yield | 0.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Lithium Americas (LAC) trades at $2.41, down 5.12% on the day, reflecting ongoing market pressure despite recent earnings beats. The stock shows mixed signals with bearish technical indicators but bullish analyst sentiment, with 7 buy ratings and a $4.00 consensus price target. The company remains in development phase with no current revenue, reporting negative EBITDA of $51.80M for 2025, but has secured substantial financing to advance its Thacker Pass lithium project.
LAC presents a high-risk, high-reward opportunity as it transitions from development to execution. The primary catalyst is successful commercialization of Thacker Pass, which could drive significant rerating, but investors face substantial execution risk, lithium price volatility, and continued cash burn until production begins. Analyst optimism contrasts with current financial performance, creating a speculative investment case.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
